Targeted molecular therapy of the PI3K pathway: Therapeutic significance of PI3K subunit targeting in colorectal carcinoma

Medicine and Dentistry

• Colorectal Carcinoma 100%
• Phosphoinositide 3-Kinase 100%
• Molecularly Targeted Therapy 100%
• Small Interfering RNA 45%
• Therapeutic Procedure 36%
• Colon Cancer 36%
• In Vitro 27%
• Colorectal Cancer 27%
• Tumor Suppressor Protein 18%
• Cancer Cell 18%
• Cell Viability 18%
• Liver Metastasis 18%
• Malignant Neoplasm 9%
• Cells 9%
• Gene 9%
• Mucosa 9%
• Analysis 9%
• Growth 9%
• Metastatic Carcinoma 9%
• Cancer Growth 9%
• Cell Survival 9%
• Element 9%
• Tumor Progression 9%
• Clinical Stage 9%
• Cell Proliferation 9%
• Programmed Cell Death 9%
• Green Fluorescent Protein 9%
• Plasmid 9%
• Spleen 9%
• Enzyme Active Site 9%

Biochemistry, Genetics and Molecular Biology

• Kinase 100%
• Phosphatidylinositol 100%
• Small Interfering RNA 45%
• Colon 36%
• Growth 27%
• Cancer Cell 18%
• Cell Viability 18%
• Nested Gene 9%
• Mouse 9%
• Cell Survival 9%
• Molecule 9%
• Apoptosis 9%
• Cell Proliferation 9%
• Enzyme Active Site 9%
• Green Fluorescent Protein 9%
• Mucosa 9%
• Normal Human 9%
• Nude Mouse 9%
• Genetic Code 9%
• Staining 9%

Pharmacology, Toxicology and Pharmaceutical Science

• Phosphatidylinositol 3 Kinase 100%
• Colorectal Carcinoma 100%
• Small Interfering RNA 45%
• Colon Cancer 36%
• Colorectal Cancer 27%
• Malignant Neoplasm 18%
• Liver Metastasis 18%
• Element 9%
• Mouse 9%
• Survival 9%
• Cancer Growth 9%
• Metastasis 9%
• Tumor Growth 9%
• Cell Proliferation 9%
• Antiinfective Agent 9%
• Normal Human 9%
• Nude Mouse 9%
• Apoptosis 9%
• Green Fluorescent Protein 9%